Behavioural Activation Therapy and Esketamine for Resistant Depression

Stopped The study was terminated prematurely due to significant recruitment challenges.

Conditions

• Depressive Disorder, Treatment-Resistant
• Depressive Disorder, Major
• Bipolar Disorder

Interventions

• BEHAVIORAL: Behavioural Activation (BA) Therapy
• DRUG: Esketamine

Sponsor

The Royal's Institute of Mental Health Research